TRUMENBA

Pfizer Canada Ulc🇨🇦 Health Canada

Approval Id: 3f0d3aefa471ffd8
Drug Approval Canada Name: TRUMENBA
Product Name: TRUMENBA
Status: Marketed
Status Date: 2018-01-31
Original Market Date: 2018-01-31
Din: 02468751
Drug Class: Human
Dosage Form: Suspension
Route Of Administration: Intramuscular
Schedule: Schedule D
Ahfs: 80:12.00
Atc Original: J07AH MENINGOCOCCAL VACCINES
Atc Name: j 07 ah
Aig Number: 0259551001
Company Name: Pfizer Canada Ulc
Company Address: 17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path: /organization/pfizer-canada-ulc

NEISSERIA MENINGITIDIS GRP B RECOMBINANT LIPOPROTEIN 2086 SUBFAMILY A

60 MCG / 0.5 ML

NEISSERIA MENINGITIDIS GRP B RECOMBINANT LIPOPROTEIN 2086 SUBFAMILY B

60 MCG / 0.5 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

3f0d3aefa471ffd8

Type

Standard